83 / 86
in children with cerebral palsy: a randomized trial comparing two
injection volumes. Clin Rehabil 2009;23:64–71.
86. Grunfeld A, Murray C, Solish N. Botulinum toxin for
hyperhidrosis: a review. Am J Clin Dermatol 2009;10:87–102.
87. Kreyden O. Botulinum toxin in the management of focal
hyperhidrosis. In: Benedetto A, editor. Botulinum Toxin in Clinical
Dermatology, Vol. 10. London: Taylor and Francis; 2006. p. 278–9.
88. Glaser D, Hebert A, Pariser D, Solish N. Facial hyperhidrosis: best
practice recommendations and special considerations. Cutis
2007;79(suppl 5):29–32.
89. Talarico Filho S, Nascimento M, Macedo F, Pe´cora C. A double-
blind, randomized, comparative study of two type A botulinum
toxins in the treatment of primary axillary hyperhidrosis.
Dermatol Surg 2007;33:S44–50.
90. Dressler D. Comparing botox and xeomin for axillar hype-
rhidrosis. J Neural Transm 2010;117:317–9.
91. Hexsel D, Zechmeister M, Zechmeister D, Dal’Forno T. Assessing
botulinum toxin diffusion. In: Almeida ART, Hexsel DM, editors.
Hyperhidrosis and Botulinum Toxin, Vol. 23. Edition of authors.
S a˜ o Paulo, 2004. p. 133–40.
92. Hexsel DM, Soirefmann M, Rodrigues TC, do Prado DZ. In-
creasing the field effects of similar doses of Clostridium botulinum
type A toxin-hemagglutinin complex in the treatment of com-
pensatory hyperhidrosis. Arch Dermatol 2009;145:837–40.
Address correspondence and reprint requests to: Ada R.
Trindade de Almeida, MD, Clı´nica Dermatolo´ gica do
Hospital do Servidor Pu´ blico Municipal de Sa˜o Paulo, Sa˜o
Paulo, Brazil. Rua Fa´bia, 94 apto.111A, Vila Romana, Sa˜o
Paulo, Sa˜o Paulo 05051-030, Brazil, or e-mail: artrindal@
uol.com.br3 7 : 1 1 : NOVEMBER 2 0 1 1
TR I NDADE DE ALME I DA ET AL